Liberty Capital Management Inc. Decreases Stock Position in Veeva Systems Inc. (NYSE:VEEV)

Liberty Capital Management Inc. trimmed its holdings in shares of Veeva Systems Inc. (NYSE:VEEV) by 0.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 5,884 shares of the technology company’s stock after selling 53 shares during the quarter. Liberty Capital Management Inc.’s holdings in Veeva Systems were worth $1,237,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of VEEV. MassMutual Private Wealth & Trust FSB raised its position in shares of Veeva Systems by 72.5% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 119 shares of the technology company’s stock valued at $25,000 after purchasing an additional 50 shares in the last quarter. Mowery & Schoenfeld Wealth Management LLC acquired a new stake in Veeva Systems in the third quarter valued at $26,000. True Wealth Design LLC boosted its stake in Veeva Systems by 3,375.0% during the 3rd quarter. True Wealth Design LLC now owns 139 shares of the technology company’s stock valued at $29,000 after acquiring an additional 135 shares during the last quarter. Retirement Wealth Solutions LLC acquired a new position in Veeva Systems during the 4th quarter worth $31,000. Finally, Harvest Fund Management Co. Ltd bought a new stake in shares of Veeva Systems in the 3rd quarter worth about $49,000. Hedge funds and other institutional investors own 88.20% of the company’s stock.

Insiders Place Their Bets

In other Veeva Systems news, SVP Jonathan Faddis sold 1,694 shares of the business’s stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of $230.30, for a total transaction of $390,128.20. Following the sale, the senior vice president now owns 8,061 shares in the company, valued at approximately $1,856,448.30. The trade was a 17.37 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 10.50% of the stock is currently owned by company insiders.

Veeva Systems Price Performance

NYSE VEEV opened at $237.16 on Monday. Veeva Systems Inc. has a 12 month low of $170.25 and a 12 month high of $258.93. The company has a market capitalization of $38.50 billion, a P/E ratio of 58.56, a PEG ratio of 1.97 and a beta of 0.85. The company’s 50 day simple moving average is $224.48 and its 200 day simple moving average is $214.55.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the stock. Wells Fargo & Company increased their price target on shares of Veeva Systems from $275.00 to $285.00 and gave the stock an “overweight” rating in a research report on Friday, December 6th. Canaccord Genuity Group upped their target price on Veeva Systems from $210.00 to $270.00 and gave the company a “hold” rating in a report on Friday, December 6th. Piper Sandler increased their price target on Veeva Systems from $280.00 to $290.00 and gave the stock an “overweight” rating in a research report on Friday, December 6th. Barclays boosted their price objective on Veeva Systems from $260.00 to $275.00 and gave the company an “overweight” rating in a research report on Friday, December 6th. Finally, Mizuho started coverage on Veeva Systems in a research report on Wednesday, December 4th. They issued an “outperform” rating and a $275.00 target price on the stock. Two research analysts have rated the stock with a sell rating, nine have given a hold rating and seventeen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $253.96.

About Veeva Systems

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.